146 related articles for article (PubMed ID: 31580461)
1. Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
Endo Y; Koga T; Umeda M; Furukawa K; Sasaki D; Yanagihara K; Kawakami A
Rheumatology (Oxford); 2020 Apr; 59(4):903-905. PubMed ID: 31580461
[No Abstract] [Full Text] [Related]
2. Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus.
Batu ED; Ozen S
Rheumatology (Oxford); 2020 Dec; 59(12):e155. PubMed ID: 32974675
[No Abstract] [Full Text] [Related]
3. Comment on: Successful hydroxychloroquine treatment for familial Mediterranean fever in a Japanese patient with concurrent systemic lupus erythematosus: reply.
Endo Y; Koga T; Kawakami A
Rheumatology (Oxford); 2020 Dec; 59(12):e156-e157. PubMed ID: 33097956
[No Abstract] [Full Text] [Related]
4. Familial Mediterranean Fever Imitating Lupus Flare: A Rare Coexistence of an Autoimmune Disease With an Autoinflammatory Disease.
Kiyani A; Parperis K; Parperis K
J Clin Rheumatol; 2018 Mar; 24(2):104-106. PubMed ID: 29200027
[No Abstract] [Full Text] [Related]
5. Systemic Lupus Erythematosus with Familial Mediterranean Fever: Case Report and Review of Literature.
Kokubu H; Ida H; Tanaka T; Fujimoto N
Acta Derm Venereol; 2019 Jul; 99(9):822-823. PubMed ID: 31017251
[No Abstract] [Full Text] [Related]
6. Are systemic lupus erythematosus patients carrying MEFV gene less prone to renal involvement? Report of three cases and review of the literature.
Erten S; Taskaldiran I; Yakut ZI
Ren Fail; 2013 Aug; 35(7):1013-6. PubMed ID: 23826804
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of systemic lupus erythematosus and familial Mediterranean fever in a pediatric patient.
Basaran O; Aydın F; Celikel BA; Uncu N; Cakar N
Lupus; 2016 Aug; 25(9):1062-3. PubMed ID: 26811369
[No Abstract] [Full Text] [Related]
8. Colchicine-induced myoneuropathy with myotonia in a patient with familial Mediterranean fever.
Tunç A; Gürsoy AE; Güzel V; Gökçal E; Yıldız GB
Acta Neurol Belg; 2020 Jun; 120(3):687-688. PubMed ID: 30604339
[No Abstract] [Full Text] [Related]
9. Therapeutic efficacy and adverse events of hydroxychloroquine administration in Japanese systemic/cutaneous lupus erythematosus patients.
Kishi C; Motegi SI; Yasuda M; Ishikawa O
J Dermatol; 2018 Aug; 45(8):1020-1022. PubMed ID: 30133802
[No Abstract] [Full Text] [Related]
10. Beneficial effect of hydroxychloroquine on cutaneous vasculitis in a Japanese patient with systemic lupus erythematosus.
Kibune N; Shimomura Y; Hasegawa A; Saeki T; Umemori Y; Abe R
J Dermatol; 2017 Apr; 44(4):e52-e53. PubMed ID: 27569899
[No Abstract] [Full Text] [Related]
11. Population Pharmacokinetics of Hydroxychloroquine in Japanese Patients With Cutaneous or Systemic Lupus Erythematosus.
Morita S; Takahashi T; Yoshida Y; Yokota N
Ther Drug Monit; 2016 Apr; 38(2):259-67. PubMed ID: 26587870
[TBL] [Abstract][Full Text] [Related]
12. Relapsed hydroxychloroquine induced thrombocytopenia in a systemic lupus erythematosus patient.
Antón Vázquez V; Pascual L; Corominas H; Giménez Torrecilla I
Reumatol Clin; 2017; 13(5):294-296. PubMed ID: 27263963
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus and periodic peritonitis (FMF).
Bakir F; Saaed B
Br J Rheumatol; 1989 Feb; 28(1):81-2. PubMed ID: 2917239
[No Abstract] [Full Text] [Related]
14. Case report: acute hydrops and spontaneous corneal perforation in a patient with keratoconus treated with colchicine for familial Mediterranean fever.
Hilely A; Kleinmann G
Int Ophthalmol; 2019 Jun; 39(6):1367-1369. PubMed ID: 29713855
[TBL] [Abstract][Full Text] [Related]
15. Hydroxychloroquine and lupus flare: a good drug, but we need to do better.
Crow MK; Kirou KA
Ann Rheum Dis; 2022 Mar; 81(3):303-305. PubMed ID: 35039325
[No Abstract] [Full Text] [Related]
16. Transient Pancytopenia and Granulocyte Abnormalities After Suicide Attempt With Colchicine in a Patient With Familial Mediterranean Fever.
Baysal B; Tüfekçi Ö; Erdem M; Yilmaz Ş; Ören H
J Pediatr Hematol Oncol; 2019 Aug; 41(6):489. PubMed ID: 30883459
[No Abstract] [Full Text] [Related]
17. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
Hosokawa Y; Oiwa H
Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
[TBL] [Abstract][Full Text] [Related]
18. Colchicine and Leukopenia: Clinical Implications.
Sag E; Bayindir Y; Adiguzel A; Demir S; Bilginer Y; Aytac S; Ozen S
J Pediatr; 2020 Sep; 224():166-170.e1. PubMed ID: 32417084
[TBL] [Abstract][Full Text] [Related]
19. Colchicine treatment in children with familial Mediterranean fever: is it a risk factor for neuromyopathy?
Işıkay S; Yılmaz K; Yiğiter R; Balat A; Büyükçelik M
Pediatr Neurol; 2013 Dec; 49(6):417-9. PubMed ID: 24084143
[TBL] [Abstract][Full Text] [Related]
20. Use of hydroxychloroquine in Japan.
Kishimoto M; Deshpande GA; Yokogawa N; Buyon JP; Okada M
J Rheumatol; 2012 Jun; 39(6):1296. PubMed ID: 22661421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
